Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer.
about
Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumorsCyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.Peptide receptor targeting in cancer: the somatostatin paradigm.Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide.Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts.BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells.
P2860
Q35340967-01B0539C-B478-476D-A6F7-F4443C4554B4Q36498885-D0104B12-8B97-457B-86E8-707824F430BCQ36638046-046729E7-E260-4CF7-A159-CA24170336CEQ37326746-7EADE517-A063-42C7-9E30-19B7FEBE919CQ37898112-335563FD-4AD2-45B8-A1A3-D6F08125BC89Q46933438-A4013AFF-D72A-4955-9281-89283BB5C787Q53135298-159314D4-DBF4-404F-BBCD-04E89D8136C1Q54396432-FE3A8123-497D-428A-B01C-D82E5013B1AA
P2860
Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Enhanced inhibitive effects of ...... rowth of human gastric cancer.
@en
type
label
Enhanced inhibitive effects of ...... rowth of human gastric cancer.
@en
prefLabel
Enhanced inhibitive effects of ...... rowth of human gastric cancer.
@en
P2093
P356
P1476
Enhanced inhibitive effects of ...... rowth of human gastric cancer.
@en
P2093
Chengwei Tang
Chunhui Wang
Chunlun Liu
Xuchun Zhou
P2860
P304
P356
10.1002/IJC.20256
P577
2004-11-01T00:00:00Z